CASTLEARK MANAGEMENT LLC – Revance Therapeutics, Inc. Transaction History
CASTLEARK MANAGEMENT LLC portfolio value:
$3.73M
portfolio value
CASTLEARK MANAGEMENT LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.99% | 9.03K shares | 1.94M | $27 | 138.34K |
| Q2 2022 | share | Increase | 0.00% | 129.31K shares | 1.78M | $13.82 | 129.31K |